Bill > A3768

This bill requires health benefits coverage of continuous glucose monitoring systems for the treatment of glycogen storage disease. It mandates that various types of health insurance plans, including hospital service corporation contracts, medical service corporation contracts, health service corporation contracts, individual and group health insurance policies, individual and small employer health benefits plans, and health maintenance organization contracts, provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by a healthcare practitioner, to the same extent as for any other medical condition under the plan or contract. The bill also ensures that the State Health Benefits Commission and the School Employees' Health Benefits Commission include such coverage in their purchased contracts. The provisions of the bill take effect on the first day of the seventh month following its enactment and apply to all relevant health benefits plans delivered, issued, executed, or renewed in New Jersey on or after the effective date.

Business and Industry

https://www.njleg.state.nj.us/bill-search/2022/A3768